Mylan settles Detrol LA patent litigation
The litigation is related to Mylan Pharmaceuticals’ abbreviated new drug application (ANDA) for Tolterodine Tartrate ER capsules, 2mg and 4mg, the generic version of Pfizer’s Detrol LA, indicated
Novartis has entered a collaboration with Chai Discovery to advance the use of AI in the identification of therapeutic antibodies.